HomeORY • BME
add
Oryzon Genomics SA
Previous close
€1.91
Day range
€1.90 - €1.93
Year range
€1.55 - €2.38
Market cap
117.28M EUR
Avg Volume
196.02K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.05M | -22.78% |
Net income | -1.90M | 22.97% |
Net profit margin | — | — |
Earnings per share | -0.03 | 41.03% |
EBITDA | -5.01M | -157.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 58.45M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.90M | 22.97% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
44